CHPA leadership
This article was originally published in The Tan Sheet
Executive Summary
Interim head expected to be named week of Dec. 10. Appointment will provide trade group with guidance during its search for a full-time president, board of directors notes. Permanent head expected by mid-2002. Rockville, Md.-based JDG Associates, which conducted search two years ago leading to selection of Michael Maves, MD, will again be used by CHPA. Maves is leaving for American Medical Association top post Jan. 15 (1"The Tan Sheet" Nov. 26, p. 3)...
You may also be interested in...
CHPA Has Experienced Senior VP Corps To Cover In Maves Transition
The Consumer Healthcare Products Association has a senior staff cadre with almost 100 years of experience to run the OTC/dietary supplement trade association during the search for a new director in the wake of the departure of Michael Maves, MD
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.